GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abaxis Inc (NAS:ABAX) » Definitions » Earnings per Share (Diluted)

Abaxis (Abaxis) Earnings per Share (Diluted) : $1.17 (TTM As of Mar. 2018)


View and export this data going back to 1992. Start your Free Trial

What is Abaxis Earnings per Share (Diluted)?

Abaxis's Earnings per Share (Diluted) for the three months ended in Mar. 2018 was $0.42. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2018 was $1.17.

Abaxis's EPS (Basic) for the three months ended in Mar. 2018 was $0.44. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2018 was $1.20.

Abaxis's EPS without NRI for the three months ended in Mar. 2018 was $0.42. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2018 was $1.17.


Abaxis Earnings per Share (Diluted) Historical Data

The historical data trend for Abaxis's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abaxis Earnings per Share (Diluted) Chart

Abaxis Annual Data
Trend Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 1.20 1.38 1.44 1.17

Abaxis Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.28 0.29 0.18 0.42

Competitive Comparison of Abaxis's Earnings per Share (Diluted)

For the Diagnostics & Research subindustry, Abaxis's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abaxis's PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abaxis's PE Ratio distribution charts can be found below:

* The bar in red indicates where Abaxis's PE Ratio falls into.



Abaxis Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Abaxis's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2018 is calculated as

Diluted Earnings Per Share (A: Mar. 2018 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(27.177-0)/23.135
=1.17

Abaxis's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2018 is calculated as

Diluted Earnings Per Share (Q: Mar. 2018 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(10.02-0)/23.477
=0.43

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Abaxis  (NAS:ABAX) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Abaxis Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Abaxis's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Abaxis (Abaxis) Business Description

Traded in Other Exchanges
N/A
Address
Abaxis Inc manufactures point-of-care blood analysis instruments and consumables for medical and veterinary care providers. The medical segment sells Piccolo Chemistry Analyzers, which can provide results about a blood sample in 12 minutes, and related reagents to physicians, hospitals, pharmacies, and other healthcare providers. The veterinary segment generates the majority of the firm's total revenue and sells products to animal hospitals, veterinary clinics, and private research laboratories. Products in this segment include the VetScan VS2 chemistry analyzer, animal-specific reagents, and rapid tests for canine and feline diseases. The vast majority of the firm's revenue comes from North America and Europe.
Executives
Richard Bastiani director C/O ABAXIS INC, 3240 WHIPPLE RD, UNION CITY CA 94587
Taylor Dean Ross Jr officer: CFO and VP of Finance C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Clinton Severson director, officer: CEO & Board Chairman C/O ABAXIS INC, 3240 WHIPPLE ROAD, UNION CITY CA 94587
Michael D Casey director ALLOS THERAPEUTICS, INC., 11080 CIRCLEPOINT ROAD, SUITE 200, WESTMINSTER CO 80020